Presentation Information
[L1-02]Development of LNP-mRNA vaccine against COVID-19
*Shoji Hirashima1 (1. Representative Director, Head of JBU, Daiichi Sankyo Co., LTD. (Japan))

Comment
To browse or post comments, you must log in.Log in
To browse or post comments, you must log in.Log in